Article Details

Royalty Pharma Reports Q4 2020 and Full-Year Results

Retrieved on: 2021-02-17 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

Royalty Pharma Reports Q4 2020 and Full-Year Results. View article details on hiswai:

Excerpt

$2.4 billion of acquisitions announced in 2020; maintained leading share of biopharma royalty funding market. Increasing outlook for 2020-2025 ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up